This retrospective case-control study investigated urine S100A8/A9 and S100A12 concentrations as well as the uCalR in dogs with TCC/PCA (treated or treatment-naïve), dogs with other diseases of the urinary tract, dogs with neoplastic diseases not involving the urinary tract, and healthy control dogs. This evidence concerns the gene S100A12 and neoplasm.